The Chief Executive of Moderna, Stephane Bancel, on Saturday mentioned that his firm will cost governments between Rs 1855 (USD 25) and Rs 2755 (USD 37) per dose of its COVID-19 vaccine candidate.
Talking to German weekly Welt am Sonntag (WamS), Barcel mentioned that the value of the coronavirus vaccine will rely on the variety of doses ordered by the governments.
“Our vaccine, therefore, costs about the same as a flu shot, which is between USD 10 and USD 50,” he was quoted as saying.
On Monday, an EU official concerned within the talks mentioned the European Commission wished to achieve a deal with Moderna for the availability of thousands and thousands of doses of its vaccine candidate for a worth beneath USD 25 per dose.
“Nothing is signed yet, but we’re close to a deal with the EU Commission. We want to deliver to Europe and are in constructive talks,” Bancel informed WamS, including it was only a “matter of days” till a contract could be prepared.
Moderna has mentioned its experimental vaccine is 94.5% efficient in stopping COVID-19, primarily based on interim knowledge from a late-stage medical trial, turning into the second developer to report outcomes that far exceeded expectations after Pfizer and its accomplice BioNTech.
The EU has been in talks with Moderna for its experimental COVID-19 vaccine no less than since July.
(With Reuters inputs)